Chemours refutes bankruptcy predictions

• Autores: Kasia Patel
• Localización: Industrial Minerals, ISSN 0019-8544, Nº. 585, 2016 (Ejemplar dedicado a: Julio/Agosto)
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • In a statement released by the company, Chemours said it "strongly refutes the report by Citron Research" pointing to its "five-point transformation plan" which was launched shortly after it was spun-off from parent company DuPont in July last year.

    "[Chemours] may be required to indemnify DuPont based on the separation agreement executed before the creation of Chemours through the spin-off of DuPont Performance Chemicals," the company added, but failed to elaborate further.

    "Opteon sounds great, until you realise that it's simply a replacement for R134a, which is also Chemours product, so it's simply a cannibalisation of existing business lines and existing EBITDA*," [Citron] said.